Weekly round-up #216

A Vaccine for Leprosy?

Upcoming VALIDATE Seminar - A Vaccine for Leprosy? - 28 June 2022

VALIDATE is pleased to bring you the third in our "A Vaccine for" seminar series, in which leading experts will provide an overview of the state of vaccine research for VAIDATE’s focus pathogens. In "A Vaccine for Leprosy?", Dr Khushboo Borah and Dr Chyntia Carolina Díaz Acosta will discuss the prospects for a vaccine for Leprosy, the disease caused by Mycobacteria Leprae of which there are still over 200,000 new cases of diagnosed every year.

The seminar is open to everyone (including non-members), so please spread the word. This event will be especially interesting to vaccine researchers who do not study leprosy.

The event will take place at 16:00 BST, 28 June 2022 and you can register on the event webpage - www.validate-network.org/event/a-vaccine-for-leprosy


  • NRF DAAD Scholarship and Fellowships - The National Research Foundation (NRF) and the German Academic Exchange Service (DAAD) award MA and PhD scholarships to South African citizens and permanent South African residents for postgraduate studies at public South African universities - various deadlines till 3 July 2022
  • NIH Global Infectious Disease Research Training Program - Encourages joint applications for the Global Infectious Disease (GID) Research Training programs from the US and low- and middle-income country (LMIC) institutions  - letter of intent deadline: 3 July 2022
  • NIH Global Infectious Disease Research Training Funding - This Funding Opportunity Announcement encourages joint applications for the Global Infectious Disease (GID) Research Training programs from the U.S. and low- and middle-income country (LMIC) institutions​​​ - deadline 3 July 2022​​​​​​
  • BactiVac Catalyst Funding for Pump-Priming Projects - Catalyst funding for pump-priming projects is available to support collaborations between Network members in bacterial vaccinology to explore new approaches and strategies to advance their vaccines research - submission deadline 10 July 2022

You can find a list of all relevant external funding we've spotted for our members on our external funding page.​​​​ ​​

More relevant career opportunities on our jobs page.

Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.

Highlights on Twitter this week:

The Conversation shared an article on the slow progress of India’s TB elimination programme, the Crick Institute Science Technology Platform training were excited to be training VALIDATE members, and a study reviewed the status of new and repurposed TB vaccines. Central Drugs Standard Control Organization in India directed the Serum Institute to investigate TB Vaccines, we shared Medical Dialogues journal club video on BCG, Ground up reported on the slow progress of the M72/AS01E vaccine for TB, and Tribune India reported on women's vaccine researchers. The Star newspaper in Kenya reported on the alarming rise in unvaccinated children, Boston Children’s hospital reported that BCG is still effective at protecting infants, and Nature discussed the methods used to decode the biology of TB. Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.


Published: 11 May 2022